Notably, the positive correlation between pre-treatment STING and PaO2 levels suggests that monocyte STING levels appear to reflect the severity of pulmonary dysfunction in IPF and may be an effective biomarker to evaluate AE-IPF. This evidence concerns the gene STING1 and idiopathic pulmonary fibrosis.